21 results on '"Mroueh R"'
Search Results
2. Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy
- Author
-
Hyytiäinen, A. (Aini), Mroueh, R. (Rayan), Peltonen, J. (Johanna), Wennerstrand, P. (Pia), Mäkitie, A. (Antti), Al-Samadi, A. (Ahmed), Ventelä, S. (Sami), Salo, T. (Tuula), Hyytiäinen, A. (Aini), Mroueh, R. (Rayan), Peltonen, J. (Johanna), Wennerstrand, P. (Pia), Mäkitie, A. (Antti), Al-Samadi, A. (Ahmed), Ventelä, S. (Sami), and Salo, T. (Tuula)
- Abstract
Treatment of oral tongue squamous cell carcinoma (OTSCC) frequently includes surgery with postoperative radiotherapy (RT) or chemoradiotherapy (CRT). Resistance to RT or CRT remains a major clinical challenge and highlights the need to identify predictive markers for it. We included 71 OTSCC patients treated with surgery combined with RT or CRT. We evaluated the association between tumor budding, tumor–stroma ratio (TSR), depth of invasion (DOI), tumor-infiltrating lymphocytes (TILs), hypoxia-inducible factor-1alpha (HIF-1alpha) expression, octamer-binding transcription factor 4 (OCT4) expression, high-endothelial venules (HEVs), and disease-free survival (DFS) using uni- and multivariate analyses. No significant association was observed between the different histological and molecular markers (TSR, DOI, TILs, HEV, HIF-1alph, OCT4) and DFS. However, an associative trend between DOI, budding, and DFS was noted. Further studies with larger cohorts are needed to explore the prognostic value of DOI and budding for OTSCC patients treated with postoperative RT or CRT.
- Published
- 2023
3. Risk of second primary cancer in oral squamous cell carcinoma
- Author
-
Mroueh, R. (Rayan), Nevala, A. (Aapeli), Haapaniemi, A. (Aaro), Pitkäniemi, J. (Janne), Salo, T. (Tuula), and Mäkitie, A. A. (Antti A.)
- Subjects
stomatognathic diseases ,head and neck cancer ,second primary cancer ,oral cancer ,second primary malignancy ,second primary tumor - Abstract
Background: The incidence and survival of oral squamous cell carcinoma (OSCC) patients have increased in recent years. Understanding their long‐term survival aspects is essential for optimal treatment and follow‐up planning. Almost one in five cancers diagnosed occurs nowadays in individuals with a previous diagnosis of cancer. Methods: Patients diagnosed with primary OSCC during 1953‐2015 were retrieved from the Finnish Cancer Registry. Both standardized incidence ratios (SIR) and excess absolute risk (EAR) per 1000 person‐years at risk (PYR) of second primary cancer (SPC) were calculated relative to the general population. Results: Among 6602 first primary OSCC patients there were 640 (10%) SPCs. The SIR for SPCs was 1.85 (95% CI: 1.71‐1.99, P
- Published
- 2020
4. Familial cancer risk in family members and spouses of patients with early‐onset head and neck cancer
- Author
-
Mroueh, R. (Rayan), Tanskanen, T. (Tomas), Haapaniemi, A. (Aaro), Salo, T. (Tuula), Malila, N. (Nea), Mäkitie, A. (Antti), Pitkäniemi, J. (Janne), Mroueh, R. (Rayan), Tanskanen, T. (Tomas), Haapaniemi, A. (Aaro), Salo, T. (Tuula), Malila, N. (Nea), Mäkitie, A. (Antti), and Pitkäniemi, J. (Janne)
- Abstract
Background: Reported patterns of familial aggregation of head and neck cancer (HNC) vary greatly, with many studies hampered by the limited number of subjects. Methods: Altogether 923 early‐onset (≤40 years old) HNC probands, their first‐degree relatives, spouses, and siblings’ offspring were ascertained. Cumulative risk and standardized incidence ratios (SIRs) were estimated. Results: Of all early‐onset HNC families, only 21 (2.3%) had familial HNC cancers at any age and less than five familial early onset HNC cancers among first‐degree relatives. The cumulative risk of HNC for siblings by age 60 (0.52%) was at population level (0.33%). No increased familial risk of early‐onset HNC could be discerned in family members (SIR 2.68, 95% CI 0.32‐9.68 for first‐degree relatives). Conclusions: Our study indicates that the cumulative and relative familial risk of early‐onset HNC is modest in the Finnish population and, at most, only a minor proportion of early‐onset HNCs are due solely to inherited genetic mutations.
- Published
- 2020
5. Non‑curative treatment of patients with oral tongue squamous‑cell carcinoma
- Author
-
Mroueh, R. (R.), Haapaniemi, A. (A.), Saarto, T. (T.), Grönholm, L. (L.), Grénman, R. (R.), Salo, T. (T.), and Mäkitie, A. A. (A. A.)
- Subjects
end of life ,surgery ,palliative care ,palliation ,quality of life ,death ,tongue cancer ,Head and neck cancer ,chemotherapy - Abstract
Purpose: Late-stage OTSCC is associated with poor overall survival (OS). Non-curative treatment approach aims to improve quality of life and prolong survival of patients deemed incurable. The purpose of this study was to investigate the used non-curative treatment modalities for OTSSC and patient survival. Methods: All patients diagnosed with OTSCC and treated with non-curative intent at the HUS Helsinki University Hospital (Helsinki, Finland) during the 12-year period of 2005–2016 were included. Survival analysis after the non-curative treatment decision was conducted using the Kaplan–Meier method in this population-based study. Results: Eighty-two patients were identified. A non-curative treatment decision was made at presentation without any previous treatment in 26 patients (7% of all patients diagnosed with OTSCC during the study period). Palliative radiotherapy was administered to 24% of all patients. The average survival time after the non-curative treatment decision was 3.7 months (median 2 and range 0–26). Conclusions: Due to the short mean survival time after decision for treatment with non-curative intent, and the notable symptom burden in this patient population, a prompt initiation of all non-curative measures is warranted.
- Published
- 2019
6. Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies
- Author
-
Almangush, A. (Alhadi), Leivo, I. (Ilmo), Siponen, M. (Maria), Sundquist, E. (Elias), Mroueh, R. (Rayan), Mäkitie, A. A. (Antti A.), Soini, Y. (Ylermi), Haglund, C. (Caj), Nieminen, P. (Pentti), Salo, T. (Tuula), Almangush, A. (Alhadi), Leivo, I. (Ilmo), Siponen, M. (Maria), Sundquist, E. (Elias), Mroueh, R. (Rayan), Mäkitie, A. A. (Antti A.), Soini, Y. (Ylermi), Haglund, C. (Caj), Nieminen, P. (Pentti), and Salo, T. (Tuula)
- Abstract
It is of great clinical importance to identify simple prognostic markers from preoperative biopsies that could guide treatment planning. Here, we compared tumor budding (B), depth of invasion (D), and the combined scores (i.e., budding and depth of invasion (BD) histopathologic model) in preoperative biopsies and the corresponding postoperative specimens of oral tongue squamous cell carcinoma (OTSCC). Tumor budding and depth of invasion were evaluated in the pre- and postoperative samples from 100 patients treated for OTSCC. Sensitivity and specificity statistics were used. Our results showed statistically significant (P < 0.001) relationship between pre- and postoperative BD scores. There was an agreement between the pre- and postoperative BD model scores in 83 cases (83%) with 57.1% sensitivity (95% CI 39.4 to 73.7%) and 96.9% specificity (95% CI 89.3 to 99.6%). Our findings suggest that the BD model, analyzed from representative biopsies, could be used for the treatment planning of OTSCC.
- Published
- 2018
7. Improved outcomes with oral tongue squamous cell carcinoma in Finland
- Author
-
Mroueh, R. (Rayan), Haapaniemi, A. (Aaro), Grénman, R. (Reidar), Laranne, J. (Jussi), Pukkila, M. (Matti), Almangush, A. (Alhadi), Salo, T. (Tuula), and Mäkitie, A. (Antti)
- Subjects
stomatognathic diseases - Abstract
Background: Incidence rates for oral tongue squamous cell carcinoma (SCC) are steadily rising worldwide. Methods: All patients diagnosed with primary oral tongue SCC at the 5 university hospitals in Finland from 2005 to 2009 were studied. The mean follow-up time was 43 months (median, 54 months; range, 0–111 months). Results: Three hundred sixty patients with primary oral tongue SCC were identified. Treatment with curative intent was provided for 328 patients (91%). The 5-year disease-specific survival (DSS) rates were as follows: stage I 87%; stage II 73%; stage III 69%; and stage IV 51%. The 5-year recurrence-free survival in general has improved from 47% in our previous published series (1995–1999) to 65% in the current series (p < .001). Conclusions: The outcome of oral tongue SCC has significantly improved in Finland. However, the relatively high number of disease recurrences in patients with stage I and II disease, when compared with patients with stage III and IV disease, calls for an investigation of new treatment approaches.
- Published
- 2017
8. Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
- Author
-
Sundquist, E. (Elias), Kauppila, J. H. (Joonas H), Veijola, J. (Johanna), Mroueh, R. (Rayan), Lehenkari, P. (Petri), Laitinen, S. (Saara), Risteli, J. (Juha), Soini, Y. (Ylermi), Kosma, V.-M. (Veli-Matti), Sawazaki-Calone, I. (Iris), Soares Macedo, C. C. (Carolina Carneiro), Bloigu, R. (Risto), Coletta, R. D. (Ricardo D), Salo, T. (Tuula), Sundquist, E. (Elias), Kauppila, J. H. (Joonas H), Veijola, J. (Johanna), Mroueh, R. (Rayan), Lehenkari, P. (Petri), Laitinen, S. (Saara), Risteli, J. (Juha), Soini, Y. (Ylermi), Kosma, V.-M. (Veli-Matti), Sawazaki-Calone, I. (Iris), Soares Macedo, C. C. (Carolina Carneiro), Bloigu, R. (Risto), Coletta, R. D. (Ricardo D), and Salo, T. (Tuula)
- Abstract
Background: Oral tongue squamous cell carcinoma (OTSCC) metastasises early, especially to regional lymph nodes. There is an ongoing debate on which early stage (T1-T2N0) patients should be treated with elective neck dissection. We need prognosticators for early stage tongue cancer. Methods: Mice immunisation with human mesenchymal stromal cells resulted in production of antibodies against tenascin-C (TNC) and fibronectin (FN), which were used to stain 178 (98 early stage), oral tongue squamous cell carcinoma samples. Tenascin-C and FN expression in the stroma (negative, moderate or abundant) and tumour cells (negative or positive) were assessed. Similar staining was obtained using corresponding commercial antibodies. Results: Expression of TNC and FN in the stroma, but not in the tumour cells, proved to be excellent prognosticators both in all stages and in early stage cases. Among early stages, when stromal TNC was negative, the 5-year survival rate was 88%. Correspondingly, when FN was negative, no cancer deaths were observed. Five-year survival rates for abundant expression of TNC and FN were 43% and 25%, respectively. Conclusions: Stromal TNC and, especially, FN expressions differentiate patients into low- and high-risk groups. Surgery alone of early stage primary tumours might be adequate when stromal FN is negative. Aggressive treatments should be considered when both TNC and FN are abundant.
- Published
- 2017
9. Preliminary results of phase II study of irinotecan and capecitabine combination as first line chemotherapy for advanced and metastatic gastric cancer
- Author
-
Farhat, F., primary, Bachour, M., additional, El Seoudi, M., additional, Kattan, J., additional, Ghosn, M., additional, Nasr, F., additional, Moukadem, W., additional, Younes, F., additional, Mroueh, R., additional, and Chahine, G., additional
- Published
- 2006
- Full Text
- View/download PDF
10. Insights into obstetric anesthesia practices: a quantitative survey among physicians across Arab countries.
- Author
-
Nafeh NA, El Khoury FM, Khalili A, Zeeni C, Karaki GA, Mroueh R, HajAli T, and Siddik-Sayyid S
- Subjects
- Humans, Female, Pregnancy, Surveys and Questionnaires, Middle East, Anesthesiologists, Practice Patterns, Physicians' statistics & numerical data, Cesarean Section statistics & numerical data, Anesthesia, Obstetrical methods
- Abstract
Background: Obstetric anesthesia guidelines are essential for standardizing obstetric anesthesia practices globally and ensuring high-quality patient care. However, practices may vary across different settings, and there are limited data from Arab countries. This study aims to gain insights into obstetric anesthesia practices in several major hospitals across Arab countries., Methods: A questionnaire was emailed to 85 obstetric anesthesiologists/anesthesia chairpersons in major hospitals, including academic medical institutions and central hospitals, across 11/22 Arab countries. This survey gathered data on key structural and process-related obstetric anesthesia indicators., Results: Out of 85 contacted, we had 56 responses (65.8%), with 41 being fully completed, providing insights into obstetric anesthesia indicators. Regarding structure: 31 (76%) hospitals had an operating room adjacent to the delivery room, all had intensive care units, and 22 (54%) had a lead obstetric anesthesiologist. For equipment, 19 (46%) had a video laryngoscope in the delivery suite, and 20 (49%) occasionally used ultrasound for epidurals. Regarding process: 33 (81%) held regular meetings, and 21 (51%) conducted research. Before epidural and spinal procedures, 26 (63%) and 28 (68%) required coagulation studies for patients without a history of hemorrhagic complications, while 38 (93%) and 36 (88%) mandated a platelet count, respectively. For labor analgesia, 34 (83%) primarily used epidurals, and 15 (37%) placed preemptive catheters in high-risk pregnancies. For cesarean delivery, 40 (98%) used spinals, with 16 (39%) using intrathecal morphine and 22 (54%) administering aspiration prophylaxis before general anesthesia. Regarding spinal-induced hypotension, 6 (15%) used prophylactic phenylephrine infusion., Conclusion: This survey highlights variations in obstetric anesthesia practices among various major hospitals in several Arab countries, compared to international recommendations. It emphasizes the need for obstetric anesthesia registries in the Arab world for future research. Further studies are required to outline country-specific practices, improve resource allocation, and enhance obstetric population safety and satisfaction., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
11. Occupational variation in the incidence of lip cancer in the Nordic countries.
- Author
-
Mroueh R, Carpén T, Mäkitie A, Hansen J, Heikkinen S, Lynge E, Martinsen JI, Selander J, Mehlum IS, Torfadottir JE, Salo T, and Pukkala E
- Subjects
- Humans, Male, Female, Incidence, Scandinavian and Nordic Countries epidemiology, Risk Factors, Lip Neoplasms epidemiology, Lip Neoplasms complications, Occupational Exposure adverse effects, Neoplasms epidemiology, Occupational Diseases epidemiology, Occupational Diseases complications
- Abstract
Introduction: While certain occupations, such as agriculture and fishery, have been associated with an increased risk of lip cancer, the occupational risk profile of lip cancer and its change over time remain poorly known. This study aims to evaluate the incidence of lip cancer across different occupations in the Nordic countries., Methods: The Nordic Occupational Cancer Study (NOCCA) covers 14.9 million people and includes 45 years of cancer incidence data, from 1961 to 2005, linked to occupational categories for all the five Nordic populations. Standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were used to quantify the risk of lip cancer across occupational categories relative to the entire national populations., Results: There were a total of 14,477 male and 3008 female lip cancer patients identified during follow up. The highest SIRs were observed among male fishermen (SIR 2.26, 95% CI: 2.04-2.50), gardeners (SIR 1.60, 95% CI: 1.48-1.72), and farmers (SIR 1.60, 95% CI: 1.55-1.66). A significantly reduced risk of lip cancer (SIR < 0.50) was observed among male physicians, teachers, religious workers, artistic workers, journalists, administrators, printers, waiters, and hairdressers. Among women, no occupations were associated with an increased risk of lip cancer., Conclusions: The incidence of lip cancer varies widely between outdoor and indoor occupations. Occupations involving outdoor activity and exposure to sunlight show the most elevated SIRs.
- Published
- 2023
- Full Text
- View/download PDF
12. Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy.
- Author
-
Hyytiäinen A, Mroueh R, Peltonen J, Wennerstrand P, Mäkitie A, Al-Samadi A, Ventelä S, and Salo T
- Subjects
- Humans, Squamous Cell Carcinoma of Head and Neck, Prognosis, Carcinoma, Squamous Cell pathology, Tongue Neoplasms therapy, Tongue Neoplasms pathology, Head and Neck Neoplasms
- Abstract
Treatment of oral tongue squamous cell carcinoma (OTSCC) frequently includes surgery with postoperative radiotherapy (RT) or chemoradiotherapy (CRT). Resistance to RT or CRT remains a major clinical challenge and highlights the need to identify predictive markers for it. We included 71 OTSCC patients treated with surgery combined with RT or CRT. We evaluated the association between tumor budding, tumor-stroma ratio (TSR), depth of invasion (DOI), tumor-infiltrating lymphocytes (TILs), hypoxia-inducible factor-1alpha (HIF-1alpha) expression, octamer-binding transcription factor 4 (OCT4) expression, high-endothelial venules (HEVs), and disease-free survival (DFS) using uni- and multivariate analyses. No significant association was observed between the different histological and molecular markers (TSR, DOI, TILs, HEV, HIF-1alph, OCT4) and DFS. However, an associative trend between DOI, budding, and DFS was noted. Further studies with larger cohorts are needed to explore the prognostic value of DOI and budding for OTSCC patients treated with postoperative RT or CRT., (© 2023 Scandinavian Societies for Pathology, Medical Microbiology and Immunology.)
- Published
- 2023
- Full Text
- View/download PDF
13. Incidence of head and neck cancer among first-generation immigrants and their children in Finland.
- Author
-
Mroueh R, Hirvonen E, Pitkäniemi J, Malila N, Hagström J, Mäkitie A, and Virtanen A
- Subjects
- Humans, Male, Child, Female, Incidence, Finland epidemiology, Risk Factors, Head and Neck Neoplasms epidemiology, Emigrants and Immigrants
- Abstract
Introduction: Limited data exist regarding head and neck cancer (HNC) burden among immigrants who may have distinct characteristics, and hence different incidence rates from the general population. Variations in behavioral habits, cultural lifestyle, or diet may cause variations across different subgroups., Methods: The whole immigrant population of Finnish residents born abroad, and their children were retrieved for the years 1970-2017. First-generation immigrants are defined as individuals born abroad, excluding their children (even if born abroad). The study comprised 0.5 million first-generation immigrants and 0.3 million children, contributing to 6 million and 5 million person-years of follow-up, respectively. Standardized incidence ratios (SIR) and excess absolute risk (EAR) per 100,000 person-years at risk were calculated to quantify the risk of HNC among immigrants relative to the general Finnish population., Results: The overall risk of any HNC was not increased among first-generation male immigrants (SIR 1.00, 95% CI: 0.88-1.15), but significantly elevated for cancer of the pharynx (SIR 1.56, 95% CI: 1.22-1.95), and larynx (SIR 1.38, 95% CI: 1.02-1.83) and decreased for lip (SIR 0.38, 95% CI: 0.20-0.67). The increased risk of pharyngeal cancer was highest among male immigrants from Asia Pacific (SIR 4.21, 95% CI: 2.02-7.75). First-generation immigrant women had a significantly reduced risk of any HNC (SIR 0.45, 95% CI: 0.37-0.55), which remained even after stratification by site. We observed no increased risk of any HNC among the children of first-generation immigrants., Conclusion: Healthcare professionals need to recognize the groups at higher HNC risk. Efforts to address the main etiological risk factors, such as smoking, are needed among the selected immigrant populations, that haven't yet reached similar decreasing trends, as in for example smoking, as the main population.NOVELTY AND IMPACTCurrently, globally, over 280 million people live outside their country of birth. Limited data exist regarding head and neck cancer (HNC) burden among immigrants who may have distinct characteristics and hence different incidence rates from the general population. Immigrant studies can provide novel data by shedding light on risk alterations and the pace of acculturation of different populations.
- Published
- 2023
- Full Text
- View/download PDF
14. Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer.
- Author
-
Jouhi L, Sikiö J, Suomalainen A, Mroueh R, Mäkitie A, and Meurman JH
- Subjects
- Humans, Papillomaviridae, Prognosis, Carcinoma, Squamous Cell pathology, Mouth Neoplasms complications, Oropharyngeal Neoplasms pathology, Papillomavirus Infections, Tongue Neoplasms complications
- Abstract
Background: Human papilloma virus is associated with oral and oropharyngeal cancer. Our aim was to examine oral health in patients with oropharyngeal (OPSCC) and oral tongue cancer (OTSCC), expecting better oral health among OPSCC patients., Material and Methods: Fifty-five OPSCC patients with known HPV status and 59 OTSCC patients were randomly selected from a list of consecutive patients of the Helsinki University Hospital, Finland. Oral health was assessed from panoramic jaw radiographs. Total Dental Index (TDI) summarizing the dental health status was calculated and Finnish population study data were used for comparison. Descriptive statistics were used for analyses., Results: Patients with HPV-positive OPSCC had higher periapical lesion index compared with HPV-negative OPSCC patients or with OTSCC patients. Residual roots were more common among OPSCC patients compared with OTSCC patients, because of their higher occurrence among HPV-negative OPSCC patients compared with OTSCC patients. Similarly, modified TDI score was significantly higher among OPSCC patients than among OTSCC patients, because of higher TDI score among HPV-negative OPSCC patients compared with OTSCC patients. OPSCC patients more often used a removable prosthesis than OTSCC patients. Dental health of the cancer patients was poorer when compared with the population data., Conclusions: Our study hypothesis was only partly confirmed. Periapical lesions were more prevalent among HPV-positive OPSCC patients, compared with the other groups. The number of residual roots was higher among HPV-negative subgroup. Thus, OPSCC patients had worse oral health parameters than OTSCC patients., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
15. CCR7 as a therapeutic target in Cancer.
- Author
-
Salem A, Alotaibi M, Mroueh R, Basheer HA, and Afarinkia K
- Subjects
- Cell Movement genetics, Cell Proliferation genetics, Humans, Ligands, Neoplasms pathology, Neoplasms therapy, Receptors, CCR7 antagonists & inhibitors, Signal Transduction genetics, Biomarkers, Tumor genetics, Molecular Targeted Therapy, Neoplasms genetics, Receptors, CCR7 genetics
- Abstract
The CCR7 chemokine axis is comprised of chemokine ligand 21 (CCL21) and chemokine ligand 19 (CCL19) acting on chemokine receptor 7 (CCR7). This axis plays two important but apparently opposing roles in cancer. On the one hand, this axis is significantly engaged in the trafficking of a number of effecter cells involved in mounting an immune response to a growing tumour. This suggests therapeutic strategies which involve potentiation of this axis can be used to combat the spread of cancer. On the other hand, the CCR7 axis plays a significant role in controlling the migration of tumour cells towards the lymphatic system and metastasis and can thus contribute to the expansion of cancer. This implies that therapeutic strategies which involve decreasing signaling through the CCR7 axis would have a beneficial effect in preventing dissemination of cancer. This dichotomy has partly been the reason why this axis has not yet been exploited, as other chemokine axes have, as a therapeutic target in cancer. Recent report of a crystal structure for CCR7 provides opportunities to exploit this axis in developing new cancer therapies. However, it remains unclear which of these two strategies, potentiation or antagonism of the CCR7 axis, is more appropriate for cancer therapy. This review brings together the evidence supporting both roles of the CCR7 axis in cancer and examines the future potential of each of the two different therapeutic approaches involving the CCR7 axis in cancer., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
16. Familial cancer risk in family members and spouses of patients with early-onset head and neck cancer.
- Author
-
Mroueh R, Tanskanen T, Haapaniemi A, Salo T, Malila N, Mäkitie A, and Pitkäniemi J
- Subjects
- Adult, Family, Finland epidemiology, Genetic Predisposition to Disease, Humans, Middle Aged, Risk, Risk Factors, Head and Neck Neoplasms epidemiology, Head and Neck Neoplasms genetics, Spouses
- Abstract
Background: Reported patterns of familial aggregation of head and neck cancer (HNC) vary greatly, with many studies hampered by the limited number of subjects., Methods: Altogether 923 early-onset (≤40 years old) HNC probands, their first-degree relatives, spouses, and siblings' offspring were ascertained. Cumulative risk and standardized incidence ratios (SIRs) were estimated., Results: Of all early-onset HNC families, only 21 (2.3%) had familial HNC cancers at any age and less than five familial early onset HNC cancers among first-degree relatives. The cumulative risk of HNC for siblings by age 60 (0.52%) was at population level (0.33%). No increased familial risk of early-onset HNC could be discerned in family members (SIR 2.68, 95% CI 0.32-9.68 for first-degree relatives)., Conclusions: Our study indicates that the cumulative and relative familial risk of early-onset HNC is modest in the Finnish population and, at most, only a minor proportion of early-onset HNCs are due solely to inherited genetic mutations., (© 2020 The Authors. Head & Neck published by Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
17. Risk of second primary cancer in oral squamous cell carcinoma.
- Author
-
Mroueh R, Nevala A, Haapaniemi A, Pitkäniemi J, Salo T, and Mäkitie AA
- Subjects
- Humans, Incidence, Registries, Risk Factors, Squamous Cell Carcinoma of Head and Neck epidemiology, Carcinoma, Squamous Cell epidemiology, Carcinoma, Squamous Cell therapy, Head and Neck Neoplasms, Mouth Neoplasms epidemiology, Mouth Neoplasms therapy, Neoplasms, Second Primary epidemiology
- Abstract
Background: The incidence and survival of oral squamous cell carcinoma (OSCC) patients have increased in recent years. Understanding their long-term survival aspects is essential for optimal treatment and follow-up planning. Almost one in five cancers diagnosed occurs nowadays in individuals with a previous diagnosis of cancer., Methods: Patients diagnosed with primary OSCC during 1953-2015 were retrieved from the Finnish Cancer Registry. Both standardized incidence ratios (SIR) and excess absolute risk (EAR) per 1000 person-years at risk (PYR) of second primary cancer (SPC) were calculated relative to the general population., Results: Among 6602 first primary OSCC patients there were 640 (10%) SPCs. The SIR for SPCs was 1.85 (95% CI: 1.71-1.99, P < .001) corresponding to an EAR of 8.78 (95% CI: 7.29-10.26)., Conclusions: Health care professionals should be aware of the second primary cancer risk after management of primary OSCC and patients need to be counseled about this phenomenon., (© 2020 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
18. A descriptive study highlighting the differences in the treatment protocol for oral tongue cancer in Sweden and Finland.
- Author
-
Mäkitie A, Kamali A, Mroueh R, Lindford A, Koivunen P, Autio T, Lassus P, Halle M, Bäck L, Palmgren B, and Hammarstedt-Nordenvall L
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell radiotherapy, Female, Finland epidemiology, Humans, Male, Middle Aged, Retrospective Studies, Sweden epidemiology, Tongue Neoplasms mortality, Tongue Neoplasms radiotherapy, Young Adult, Carcinoma, Squamous Cell surgery, Plastic Surgery Procedures statistics & numerical data, Tongue Neoplasms surgery
- Abstract
Background and aims: Stage II cancer of the tongue is mostly managed surgically both locally and regionally. However, indications for postoperative radiotherapy and reconstructive options vary between centers. This paper aims to describe differences in treatment in a geographically homogenous cohort. Methods: A retrospective comparison was made between two cohorts of clinical T2N0 tongue cancer from Finland and Sweden. The Finnish cohort included 75 patients and the Swedish 54. All patients had curative intent of treatment and no previous head and neck cancer. Data analyzed consisted of pathological stage, size and thickness of tumor, frequency of reconstruction, radiotherapy delivered, and survival. Results: The Finnish cohort included a higher proportion of patients managed with reconstructive surgery (67%) than the Swedish cohort (0%), p < .00001. More patients were treated with postoperative radiotherapy (84%) in the Swedish cohort than in the Finnish (54%), p < .0002. The Finnish cohort had a higher level of survival and included more frequent downstaging (cTNM to pTNM). Conclusions and significance: Our data indicate a major difference in the management of T2N0 oral tongue cancer. The optimal cut-off size and growth pattern of the tumor warranting reconstruction should be further evaluated in a prospective manner considering both survival and quality of life.
- Published
- 2020
- Full Text
- View/download PDF
19. Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.
- Author
-
Almangush A, Leivo I, Siponen M, Sundquist E, Mroueh R, Mäkitie AA, Soini Y, Haglund C, Nieminen P, and Salo T
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell surgery, Female, Humans, Male, Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Postoperative Period, Preoperative Period, Prognosis, Sensitivity and Specificity, Tongue Neoplasms diagnosis, Tongue Neoplasms surgery, Carcinoma, Squamous Cell pathology, Models, Biological, Tongue Neoplasms pathology
- Abstract
It is of great clinical importance to identify simple prognostic markers from preoperative biopsies that could guide treatment planning. Here, we compared tumor budding (B), depth of invasion (D), and the combined scores (i.e., budding and depth of invasion (BD) histopathologic model) in preoperative biopsies and the corresponding postoperative specimens of oral tongue squamous cell carcinoma (OTSCC). Tumor budding and depth of invasion were evaluated in the pre- and postoperative samples from 100 patients treated for OTSCC. Sensitivity and specificity statistics were used. Our results showed statistically significant (P < 0.001) relationship between pre- and postoperative BD scores. There was an agreement between the pre- and postoperative BD model scores in 83 cases (83%) with 57.1% sensitivity (95% CI 39.4 to 73.7%) and 96.9% specificity (95% CI 89.3 to 99.6%). Our findings suggest that the BD model, analyzed from representative biopsies, could be used for the treatment planning of OTSCC.
- Published
- 2018
- Full Text
- View/download PDF
20. Improved outcomes with oral tongue squamous cell carcinoma in Finland.
- Author
-
Mroueh R, Haapaniemi A, Grénman R, Laranne J, Pukkila M, Almangush A, Salo T, and Mäkitie A
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Chemoradiotherapy methods, Cohort Studies, Combined Modality Therapy, Disease-Free Survival, Female, Finland, Hospitals, University, Humans, Male, Middle Aged, Mouth Neoplasms pathology, Mouth Neoplasms therapy, Neoplasm Invasiveness pathology, Neoplasm Staging, Prognosis, Radiotherapy, Adjuvant, Plastic Surgery Procedures methods, Retrospective Studies, Risk Assessment, Survival Analysis, Tongue Neoplasms mortality, Tongue Neoplasms pathology, Treatment Outcome, Carcinoma, Squamous Cell therapy, Glossectomy methods, Quality Improvement, Tongue Neoplasms therapy
- Abstract
Background: Incidence rates for oral tongue squamous cell carcinoma (SCC) are steadily rising worldwide., Methods: All patients diagnosed with primary oral tongue SCC at the 5 university hospitals in Finland from 2005 to 2009 were studied. The mean follow-up time was 43 months (median, 54 months; range, 0-111 months)., Results: Three hundred sixty patients with primary oral tongue SCC were identified. Treatment with curative intent was provided for 328 patients (91%). The 5-year disease-specific survival (DSS) rates were as follows: stage I 87%; stage II 73%; stage III 69%; and stage IV 51%. The 5-year recurrence-free survival in general has improved from 47% in our previous published series (1995-1999) to 65% in the current series (p < .001)., Conclusion: The outcome of oral tongue SCC has significantly improved in Finland. However, the relatively high number of disease recurrences in patients with stage I and II disease, when compared with patients with stage III and IV disease, calls for an investigation of new treatment approaches. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1306-1312, 2017., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
21. Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
- Author
-
Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma VM, Sawazaki-Calone I, Macedo CC, Bloigu R, Coletta RD, and Salo T
- Subjects
- Carcinoma, Squamous Cell metabolism, Disease Management, Female, Humans, Male, Neoplasm Staging, Prognosis, Survival Analysis, Tongue Neoplasms metabolism, Carcinoma, Squamous Cell pathology, Fibronectins metabolism, Stromal Cells metabolism, Tenascin metabolism, Tongue Neoplasms pathology
- Abstract
Background: Oral tongue squamous cell carcinoma (OTSCC) metastasises early, especially to regional lymph nodes. There is an ongoing debate on which early stage (T1-T2N0) patients should be treated with elective neck dissection. We need prognosticators for early stage tongue cancer., Methods: Mice immunisation with human mesenchymal stromal cells resulted in production of antibodies against tenascin-C (TNC) and fibronectin (FN), which were used to stain 178 (98 early stage), oral tongue squamous cell carcinoma samples. Tenascin-C and FN expression in the stroma (negative, moderate or abundant) and tumour cells (negative or positive) were assessed. Similar staining was obtained using corresponding commercial antibodies., Results: Expression of TNC and FN in the stroma, but not in the tumour cells, proved to be excellent prognosticators both in all stages and in early stage cases. Among early stages, when stromal TNC was negative, the 5-year survival rate was 88%. Correspondingly, when FN was negative, no cancer deaths were observed. Five-year survival rates for abundant expression of TNC and FN were 43% and 25%, respectively., Conclusions: Stromal TNC and, especially, FN expressions differentiate patients into low- and high-risk groups. Surgery alone of early stage primary tumours might be adequate when stromal FN is negative. Aggressive treatments should be considered when both TNC and FN are abundant.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.